Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 36184748

Irinotecan dose schedule for the treatment of Ewing sarcoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Pediatr Blood Cancer
Publication date
2023 Jan
First author
Slotkin EK

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Pediatr Blood Cancer. 2023 Apr;70(4):e30124. doi: 10.1002/pbc.30124.
    note
    Source null
    related pmid
    36495251
    relationship
    Comment in

Authors and identifiers

  1. name
    Slotkin EK
    type
    Author
  2. name
    Meyers PA
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Slotkin EK
    type
    Author
  2. name
    Meyers PA
    type
    Author
bibliography ids
  1. nci-bib-5aeae716adc4bbe99aa93082
book metadata
content sha256
7adeb7e506e75dcca03d41e6199f6e91a8aa4f2afb3532f427e80e2051b513dd
document type
citation
dois
  1. 10.1002/pbc.30005
electronic publication date
display
2022 Oct 2
precision
day
year
2022
evidence scope
bibliographic_metadata_only
id
pubmed:36184748
immutable id
pubmed:36184748@7adeb7e506e75dcca03d41e6199f6e91a8aa4f2afb3532f427e80e2051b513dd
journal
abbreviation
Pediatr Blood Cancer
issn electronic
1545-5017
issn print
1545-5009
issue
1
name
Pediatric blood & cancer
nlm unique id
101186624
pages
e30005
volume
70
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Pediatr Blood Cancer. 2023 Apr;70(4):e30124. doi: 10.1002/pbc.30124.
    note
    Source null
    related pmid
    36495251
    relationship
    Comment in
outcomes validated
false
pmid
36184748
provenance
batch id
d370e99271168e8a8a13
provider
NCBI PubMed ESummary
record sha256
3faca1f8724e501ccabe6feef66457f777fe06b116b382e457ce2ca78239d8fd
response sha256
f65ace3ceb1efa86f3fbab8e01ce265243e7c6b7f13c5f71c357c1f219ad79c4
retrieved at
2026-09-09T23:48:13.005737+00:00
publication date
display
2023 Jan
precision
month
year
2023
publication types
  1. Review
  2. Journal Article
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/36184748/
title
Irinotecan dose schedule for the treatment of Ewing sarcoma.

Preserved source evidence · Not medical advice